文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

儿童癌症幸存者中的铁过载

Iron Overload in Survivors of Childhood Cancer.

作者信息

Trovillion Erin Murphy, Schubert Lynn, Dietz Andrew C

机构信息

Division of Pediatric Hematology/Oncology/BMT, Rady Children's Hospital, San Diego.

Children's Center for Cancer and Blood Diseases, Children's Hospital Los Angeles, University of Southern California, Los Angeles, CA.

出版信息

J Pediatr Hematol Oncol. 2018 Jul;40(5):396-400. doi: 10.1097/MPH.0000000000000887.


DOI:10.1097/MPH.0000000000000887
PMID:28562518
Abstract

BACKGROUND: Patients transfused with packed red blood cells (PRBC), including childhood cancer survivors (CCS), experience complications. We describe iron overload (ferritin>500 ng/mL) prevalence and identify risk factors in CCS. OBSERVATIONS: Of 116 participants, 3 (2.6%) had elevated ferritin. All were teenagers at cancer diagnosis and received >8000 mL PRBC. Total PRBC volume correlated best with elevated ferritin (r=0.74; P<0.0001). PRBC (8000 mL) had the best positive and negative predictive value (75% and 100%, respectively) for iron overload. CONCLUSIONS: CCS may have iron overload. Overall prevalence is low. At-risk include teenagers at diagnosis and those receiving higher total PRBC volumes.

摘要

背景:包括儿童癌症幸存者(CCS)在内的接受浓缩红细胞(PRBC)输血的患者会出现并发症。我们描述了铁过载(铁蛋白>500 ng/mL)的患病率,并确定了CCS中的风险因素。 观察结果:在116名参与者中,3人(2.6%)铁蛋白升高。所有患者在癌症诊断时均为青少年,且接受了超过8000 mL的PRBC。PRBC总量与铁蛋白升高的相关性最佳(r=0.74;P<0.0001)。PRBC(8000 mL)对铁过载具有最佳的阳性和阴性预测价值(分别为75%和100%)。 结论:CCS可能存在铁过载。总体患病率较低。有风险的人群包括诊断时为青少年以及接受PRBC总量较高的患者。

相似文献

[1]
Iron Overload in Survivors of Childhood Cancer.

J Pediatr Hematol Oncol. 2018-7

[2]
Iron Overload in Children with Leukemia Receiving Multiple Blood Transfusions.

Indian Pediatr. 2018-11-15

[3]
Characterization of transfusion-derived iron deposition in childhood cancer survivors.

Cancer Epidemiol Biomarkers Prev. 2014-9

[4]
Iron Overload in Survivors of Childhood Cancer.

J Pediatr Hematol Oncol. 2016-1

[5]
An assessment of iron overload in children treated for cancer and nonmalignant hematologic disorders.

Eur J Pediatr. 2014-9

[6]
Association of projected transfusional iron burden with treatment intensity in childhood cancer survivors.

Pediatr Blood Cancer. 2011-12-20

[7]
Iron overload in adults with sickle cell disease who have received intermittent red blood cell transfusions.

J Am Assoc Nurse Pract. 2015-10

[8]
Prevalence of iron overload in pediatric oncology patients after blood transfusion.

Clin Adv Hematol Oncol. 2012-6

[9]
Iron overload in children undergoing cancer treatments.

Pediatr Blood Cancer. 2013-7-29

[10]
Risk factors for hyperferritinemia secondary to red blood cell transfusions in pediatric cancer patients.

Pediatr Blood Cancer. 2013-6-17

引用本文的文献

[1]
Assessment of transfusion-induced iron overload with T2*MRI in survivors of childhood acute lymphoblastic leukemia: A case control study.

Hematol Transfus Cell Ther. 2024-12

[2]
Iron Overload in Children with Acute Lymphoblastic and Acute Myeloblastic Leukemia-Experience of One Center.

Cancers (Basel). 2024-1-15

[3]
Radiomics nomograms based on R2* mapping and clinical biomarkers for staging of liver fibrosis in patients with chronic hepatitis B: a single-center retrospective study.

Eur Radiol. 2023-3

[4]
Blood product administration during high risk neuroblastoma therapy.

Pediatr Hematol Oncol. 2020-2

[5]
Hepatic late adverse effects after antineoplastic treatment for childhood cancer.

Cochrane Database Syst Rev. 2019-4-15

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索